Denali Therapeutics (D2NL34.SA) Q3 2024 Earnings

Aug 1Confirmed
Q4 2023
Q2 2024
Q3 2024
-4.24
-3.96
-3.68
-3.39

Details

Expected EPS
-4.039595229000001
Actual EPS
-3.3928540000000003
Surprise EPS
0.65
Surprise Percent
+16.01%

Description

⁨Denali Therapeutics⁩ (⁦D2NL34.SA⁩) has reported earnings of ⁦-3.3928540000000003⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts